Work

Lenalidomide following fludarabine and rituximab in previously untreated CLL

Year: 2015

Type: article

Abstract: Introduction Chronic lymphocytic leukemia (CLL) is the most common form of adult leukemia in the western world, affecting about 15,000 new patients each year in the United States [1]. Whereas most patients do not require therapy at diagnosis, CLL often progresses and treatment is indicated for signs or symptoms of the

Source: Hematology and Leukemia

DOI: 10.7243/2052-434x-3-2

Authors: Chaitra Ujjani, Aneel Paulus, Edmund Gehan, Saad Jamshed, Tingting Zhuang, Kasyapa Chitta, Gaihua Zhang, Yan Asmann, Jeanette Crawford, Bruce D Cheson

Institutions: Georgetown University Medical Center, Georgetown Lombardi Comprehensive Cancer Center, Mayo Clinic in Florida, Mayo Clinic Comprehensive Cancer Center (Florida), Rochester General Hospital, University at Buffalo, State University of New York

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

Funder: Mayo Clinic

OpenAlex ID: W779604009

FWCI:

Cites: 24

Cited by:

Related to: 10